Dynamics of fractalkine among Kharkiv residents with different body mass

Main Article Content

K.V. Misiura
P.P. Kravchun


Background. When developing individual approaches to treating obesity and comorbid diseases, the presence and severity of inflammation in adipose tissue should be taken into account, as it significantly affects its metabolism and secretion. One of the markers of inflammatory activity in adipose tissue is the circulatory level of fractalkine in the blood. The purpose of the study was to assess fractalkine level among representatives of Ukrainian population — residents of Kharkiv, depending on their body mass index, degree and topography of deposition of adipose tissue. Materials and methods. The study included 250 adult residents of Kharkiv. Level of fractalkine in circulation was defined by immunoenzyme method. We have analyzed the correlation between fractalkine and body mass index, the presence and degree of abdominal obesity, contents of adipose tissue, insulin level and index of insulin resistance HOMA. Results. It was found that the determining factor regarding the uncontrolled accumulation of adipose tissue is increased level of fractalkine. The direct connection was established between fractalkine level and sensitivity of tissues to insulin. Conclusions. It was found that body fat mass parameter is more informative in relation to the level of fractalkine than body mass index parameter.

Article Details

How to Cite
Misiura, K., and P. Kravchun. “Dynamics of Fractalkine Among Kharkiv Residents With Different Body Mass”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 13, no. 3, June 2017, pp. 135-42, doi:10.22141/2224-0721.13.3.2017.104109.
Original Researches


World Health Organization. Obesity and overweight. 2016. www.who.int/mediacentre/factsheets/fs311/en/

Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet. 2014 Mar;383(9921):970-83. doi: 10.1016/S0140–6736 (13)61836-X.

Cancello R, Henegar C, Viguerie N, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes. 2005;54(8):2277-86. PMID: 16046292.

Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112(12):1796-808. doi: 10.1172/JCI19246.

Cancello R, Tordjman J, Poitou C. et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes. 2006;55(6):1554-61. doi: 10.2337/db06-0133.

Cinti S, Mitchell G, Barbatelli G, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 2005;46(11):2347-55. doi: 10.1194/jlr.M500294-JLR200.

Kang K, Reilly SM, Karabacak V, et al. Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Cell Metab. 2008;7(6):485-95. doi: 10.1016/j.cmet.2008.04.002.

Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest. 2006 Jun;116(6):1494-505. doi: 10.1172/JCI26498.

Garton KJ, Gough PJ, Blobel CP, et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem. 2001;276(41):7993-8001. doi: 10.1074/jbc.M106434200.

Hundhausen C, Misztela D, Berkhout TA, et al. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood. 2003;102(4):1186-95. doi: 10.1182/blood-2002-12-3775.

Hyakudomi M, Matsubara T, Hyakudomi R, et al. Increased expression of fractalkine is correlated with a better prognosis and an increased number of both CD8+ T cells and natural killer cells in gastric adenocarcinoma. Ann Surg Oncol. 2008;15(6):1775-82. doi: 10.3748%2Fwjg.v20.i15.4428.

Ikejima H, Imanishi T, Tsujioka H, et al. Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris. Circulation J. 2010;74(2):337-45. PMID: 20019415.

Liu H, Jiang D, Zhang S, Ou B. Aspirin inhibits fractalkine expression in atherosclerotic plaques and reduces atherosclerosis in ApoE gene knockout mice. Cardiovascular Drugs and Therapy. 2010 Feb;24(1):17-24. doi: 10.1007/s10557-009-6210-7.

White GE, Tan TC, John AE, et al. Fractalkine has antiapoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signaling. Cardiovascular Res. 2010;85:825-35. doi: 10.1093/cvr/cvp341.

Schäfer A, Schulz C, Fraccarollo D, et al. The CX3C chemokine fractalkine induces vascular dysfunction by generation of superoxide anions. Arterioscler Thromb Vasc Biol. 2007;27(1):55-62. doi: 10.1161/01.ATV.0000251535.30191.60.

Mizutani N, Sakurai T, Shibata T, et al. Dose-dependent differential regulation of cytokine secretion from macrophages by fractalkine. Immunology. 2007;179(11):7478-87. PMID: 18025192.

Lee YS, Morinaga H, Kim JJ, et al. The Fractalkine/CX3CR1 System Regulates β Cell Function and Insulin Secretion. Cell. 2013;153(2):413-25. doi: 10.1016/j.cell.2013.03.001.

Garvey WT, Garber AJ, Mechanick JI, Bray GA, et al. The American Association of Clinical Endocrinologists and the American College of Endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. Endocr Pract. 2014 Sep; 20(9):977-89. doi: 10.4158/EP14280.PS.

Most read articles by the same author(s)